title: Percutaneous radiofrequency ablation of hepatocellular lesions in segment II of the liver: a risk factor for cardiac tamponade.
abstract: Percutaneous radiofrequency ablation (PRFA) is a minimally invasive procedure used for the treatment of small hepatocellular carcinomas. PRFA is regarded as a much safer alternative to surgical resection or orthotopic liver transplantation. However, serious complications, including cardiac tamponade, have been reported. Two cases of severe cardiac tamponade during PRFA were successfully treated.
authors.affiliation: Department of Anesthesiology, Montefiore Medical Center, Bronx, NY 10467, USA. Electronic address: esilverm@montefiore.org.
authors.forename: Eric R
authors.initials: ER
authors.lastname: Silverman
authors.forename: Yan H
authors.initials: YH
authors.lastname: Lai
authors.forename: Irene P
authors.initials: IP
authors.lastname: Osborn
authors.forename: Francine S
authors.initials: FS
authors.lastname: Yudkowitz
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D002305:Cardiac Tamponade / Q000209:etiology* / Q000503:physiopathology; D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D008297:Male; D012307:Risk Factors; D016896:Treatment Outcome
keywords: Cardiac tamponade; Hepatocellular carcinoma; Liver carcinoma; Percutaneous radiofrequency ablation; Thermoablation